Adj Gary Reubenson

Gary Reubenson is a South African clinician-researcher in pediatric infectious diseases, closely associated with national surveillance platforms and academic hospital networks. His work spans clinical care, public health, and laboratory-based epidemiology, with contributions to high-impact journals addressing vaccine-preventable diseases and emerging infections. He collaborates extensively in multicountry consortia focused on child health and infectious disease control.

His research centers on respiratory pathogens and vaccine impact, including pneumococcal disease, RSV, pertussis, and SARS-CoV-2. Through national laboratory surveillance and genomic characterization studies, he has examined pathogen evolution, outbreak dynamics, and indirect vaccine effects across age groups. Recent studies explore COVID-19 severity trends in children, variant-associated outcomes, and risk factors for hospitalization, informing pediatric vaccination and mitigation strategies.

Additional contributions address fungal and opportunistic infections such as Candida auris and cryptococcal disease in HIV-affected populations, highlighting antimicrobial resistance and screening program impact. Collectively, his scholarship demonstrates strengths in large-scale data analysis, sentinel surveillance, and translational epidemiology, shaping infectious disease policy and pediatric clinical practice in South Africa and globally.